
Krystal Biotech KRYS
$ 261.98
-4.96%
Annual report 2025
added 02-17-2026
Krystal Biotech P/S Ratio 2011-2026 | KRYS
Annual P/S Ratio Krystal Biotech
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21.7 | 17.3 | 84.7 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.7 | 17.3 | 41.2 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
11.7 | $ 2.19 | -9.77 % | $ 226 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 3.34 | 0.45 % | $ 3.9 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Codexis
CDXS
|
4.91 | $ 1.02 | 1.49 % | $ 74.9 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.74 | 3.6 % | $ 1.12 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Cerus Corporation
CERS
|
1.49 | $ 2.6 | 1.37 % | $ 480 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Cellectis S.A.
CLLS
|
6.69 | $ 3.87 | -0.39 % | $ 116 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Collegium Pharmaceutical
COLL
|
6.81 | $ 41.75 | 0.19 % | $ 1.32 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
4.93 | $ 36.14 | 1.23 % | $ 3.75 B | ||
|
Amarin Corporation plc
AMRN
|
1.43 | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
5.16 | $ 23.77 | 2.99 % | $ 2.91 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
2.86 | $ 8.41 | -1.87 % | $ 36.4 M | ||
|
Cardiff Oncology
CRDF
|
196 | $ 1.94 | 0.01 % | $ 130 M | ||
|
Curis
CRIS
|
1.21 | $ 1.1 | -3.51 % | $ 6.94 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
CorMedix
CRMD
|
2.09 K | $ 7.16 | 0.42 % | $ 364 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Champions Oncology
CSBR
|
1.86 | $ 6.14 | 3.89 % | $ 83.9 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Citius Pharmaceuticals
CTXR
|
1.21 K | $ 0.72 | -2.34 % | $ 4.84 M | ||
|
Aridis Pharmaceuticals
ARDS
|
1.34 | - | 17.91 % | $ 11.1 M | ||
|
Altimmune
ALT
|
23.1 K | $ 4.21 | -2.32 % | $ 299 M | ||
|
CEL-SCI Corporation
CVM
|
366 | $ 3.88 | -8.92 % | $ 247 M |